` Comparison: 6600, NOVO B - Alpha Spread

S
6600
vs
NOVO B

Over the past 12 months, SciClone Pharmaceuticals (Holdings) Ltd has underperformed NOVO B, delivering a return of 0% compared to the NOVO B's 62% drop.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
6600
NOVO B
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

S
Intrinsic Value
Not Available
NOVO B Intrinsic Value
551.92 DKK
Undervaluation 37%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
S
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
18.72 HKD
Novo Nordisk A/S
CSE:NOVO B
345.9 DKK
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
6600, NOVO B

6600
NOVO B
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
S
SciClone Pharmaceuticals (Holdings) Ltd
Revenue
Novo Nordisk A/S
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
6600, NOVO B

6600
NOVO B
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
S
SciClone Pharmaceuticals (Holdings) Ltd
HKEX:6600
Novo Nordisk A/S
CSE:NOVO B
What is Free Cash Flow?

Gross Margin

SciClone Pharmaceuticals (Holdings) Ltd
74.7%
NOVO B
84%

Operating Margin

SciClone Pharmaceuticals (Holdings) Ltd
39.9%
NOVO B
45.8%

Net Margin

SciClone Pharmaceuticals (Holdings) Ltd
35.6%
NOVO B
35.6%

FCF Margin

SciClone Pharmaceuticals (Holdings) Ltd
42%
NOVO B
19.8%

ROE

SciClone Pharmaceuticals (Holdings) Ltd
35.9%
NOVO B
79.2%

ROA

SciClone Pharmaceuticals (Holdings) Ltd
27%
NOVO B
26.1%

ROIC

SciClone Pharmaceuticals (Holdings) Ltd
66.5%
NOVO B
31.7%

ROCE

SciClone Pharmaceuticals (Holdings) Ltd
37.4%
NOVO B
62.6%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
6600, NOVO B

Loading
6600
NOVO B
Add Stock
www.alphaspread.com

Performance Gap
6600, NOVO B

Loading
6600
NOVO B
Difference
www.alphaspread.com

Performance By Year
6600, NOVO B

Loading
6600
NOVO B
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare 6600 to other stocks
Unlock Full Access to Alpha Spread
Create Free Account